Skip to main content
IMNMHealthcare

Immunome Inc (IMNM) Insider Trading

In the last 90 days, 3 Immunome Inc (IMNM) insiders reported no open-market purchases and 4 sales totaling $5,747,142. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 11, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 11, 2026Jack HigginsChief Scientific OfficerSale13,200$25.32$334,224
Aug 12, 2026Isaac BarchasDirectorSale83,464$26.35$2,198,909
Aug 7, 2026Isaac BarchasDirectorSale36,088$26.06$940,453
Aug 4, 2026Kinney HornCHIEF BUSINESS OFFICERSale90,616$25.09$2,273,555
Jul 7, 2026Kinney HornCHIEF BUSINESS OFFICERSale1,092$25.00$27,300
Jul 7, 2026Isaac BarchasDirectorSale100,000$24.13$2,412,520
Jul 2, 2026Robert LechleiderChief Medical OfficerSale55,000$22.62$1,244,331
Jul 2, 2026Isaac BarchasDirectorSale201,050$21.85$4,393,023
Jun 25, 2026Robert LechleiderChief Medical OfficerSale55,000$19.85$1,091,662
Jun 15, 2026Max RosettChief Financial OfficerSale60,000$18.23$1,093,800

Common questions

IMNM insider trading FAQ

Are IMNM insiders buying or selling?
Over the last 90 days, IMNM insiders were net sellers, reporting $0.00 of open-market purchases and $5,747,142 of sales.
When was the last IMNM insider purchase?
No open-market insider purchase of Immunome Inc stock was reported in the last 90 days.
Where does IMNM insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Immunome Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.